A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

NCT05017987 ·Status: COMPLETED ·Phase: PHASE1

AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

NCT00995605 ·Status: TERMINATED ·Phase: PHASE1

Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers

NCT04688580 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects

NCT04416126 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

NCT06887010 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants

NCT03501069 ·Status: TERMINATED ·Phase: PHASE1

A Phase I Dosing Study of IkT-148009.

NCT06641557 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers

NCT04856969 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide

NCT05097716 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men

NCT04123288 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

NCT03866928 ·Status: COMPLETED ·Phase: PHASE1

A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

NCT01048203 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

NCT01422135 ·Status: COMPLETED ·Phase: PHASE1

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

NCT06019936 ·Status: UNKNOWN ·Phase: PHASE2

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

NCT06539507 ·Status: RECRUITING ·Phase: PHASE1

Pilot Study of AVT16 in Healthy Adult Subjects

NCT06400719 ·Status: COMPLETED ·Phase: PHASE1

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

NCT00619931 ·Status: COMPLETED ·Phase: PHASE1

14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man

NCT01176201 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

NCT03362437 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

NCT02442258 ·Status: COMPLETED ·Phase: PHASE1

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

NCT04183686 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients

NCT02778386 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

NCT07219030 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

NCT00959816 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)

NCT01244035 ·Status: COMPLETED ·Phase: PHASE1